Help us: Donate
Follow us on:
×

Tag: Joe Betts Lacroix

February 12, 2020
Our friends at Foresight Institute and 100 Plus Capital have started regular longevity salons to coordinate the growing longevity enthusiasm and onboard new investors into the space. You are invited to kick off this series with aperitifs and hors d'oeuvre to discuss the current innovations that have been fueling the recent optimism in the field:...
October 28, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Joe Betts-LaCroix discussed the prioritization of aging compared to other government programs, the relationship between finance and human health, funding...
October 19, 2018
Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union, New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights. Joe Betts Lacroix of Y Combinator and Vium discusses the...
October 03, 2018
Today, we have another video from our Ending Age-Related Diseases 2018 conference, which was held earlier this year at the Cooper Union in New York City. The conference was designed to bring the worlds of research and investment together in one place and explore the progress and challenges that the industry faces in developing and...
July 18, 2018
On July 12th, we hosted our first conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus in New York City. We are delighted to announce that the conference was a huge success with 160 attendees, a wide variety of speakers...
May 25, 2018
BRINGING REJUVENATION BIOTECHNOLOGY AND INVESTORS TOGETHER At the Frederick P. Rose Auditorium, Cooper Union in New York City, we will be hosting a special one-day conference focused on aging research and biotech investment. Developing therapies from initial concepts, through clinical testing, and ultimately to market takes a pipeline, and right now, that pipeline is being...